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The article discusses the drugs being used to enhance performance and to limit mental fatigue among 
soldiers and its repercussions. It is a known fact that amphetamines such as Dexedrine are commonly 
prescribed to keep pilots alert even though questions have been raised about safety. The air force is 
considering alternatives to amphetamines, in particular a medication that has also gained the attention of 
long-distance business travelers, modafinil and the ampakines. 
Comments 
Postprint version. Published in Scientific American Mind, Volume 17, Issue 6, December 2006, pages 
66-73. 
NOTE: At the time of publication, the author Jonathan D. Moreno was affiliated with the University of 
Virginia. Currently January 2008, he is a faculty member at the Center for Cognitive Neuroscience at the 
University of Pennsylvania. 
This journal article is available at ScholarlyCommons: https://repository.upenn.edu/neuroethics_pubs/33 
Scientific American: Juicing the Brain http://www.sciam.com/article.cfm?id=juicing-the-brain&print=true
1 of 5 1/23/2008 10:28 AM
Scientific American Mind -  November 29, 2006
Juicing the Brain
Research to limit mental fatigue among soldiers may foster controversial ways to enhance any 
person's brain
By Jonathan D. Moreno
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Physicians have long tinkered with ways to "improve" the human brain, but as our understanding of that organ's inner
workings quickly grows, artificial enhancement is becoming more feasible. Military research is at the forefront of this 
work, much of it focused on drugs. The goal is to produce a better soldier, but the emerging techniques could just as 
easily be applied to any individual.
The military wants to juice up personnel's brains because the human being is the weakest instrument of warfare. 
Although for centuries astonishing and terrifying advances have been made in the technology of conflict, soldiers are 
basically the same. They must eat, sleep, discern friend from foe, heal when wounded, and so forth. The first state (or 
nonstate) actor to build superior fighters will make an enormous leap in the arms race. In the short run, researchers are 
trying to devise aids that would overcome a person's inherent limitations, such as mental fatigue. Long-term results 
could lead to individuals everywhere who are tireless, less fearful or even better speakers.
Sleepless in Battle
Reducing human error caused by mental fatigue is crucial because death by "friendly fire" is a shockingly frequent 
occurrence. These tragic mistakes can partly be attributed to the sleep deprivation that accompanies lengthy 
deployments. An investigation into a 2002 incident in which two American pilots accidentally killed four Canadian 
soldiers and injured eight others in Afghanistan provided an unexpected glimpse into the U.S. Air Force's interest in 
sleep. Unnoticed by many, the pilots' attorneys in the resulting court-martial cases pointed out that their clients had been 
taking Dexedrine, sometimes called the go pill, otherwise known as speed. It was alleged that amphetamines such as 
Dexedrine are commonly prescribed to keep pilots alert for 30-hour missions, even though questions have been raised 
about safety. Use of such drugs can also lead to dependency.
The air force is considering alternatives to amphetamines, in particular a medication that has also gained the attention of
long-distance business travelers: modafinil. Marketed as Provigil, it was approved by the Food and Drug Administration 
in 1998 to treat narcolepsy and to help control sleep disorders associated with diseases such as Parkinson's, 
Alzheimer's and multiple sclerosis. Modafinil is not a traditional stimulant; rather than bombarding various parts of the 
brain with arousal signals, it apparently nudges the brain toward wakefulness through specific pathways, perhaps by 
increasing serotonin levels in the brain stem. The precise mechanism is still not well understood.
The temptation for healthy people to use such a drug is tremendous; some individuals report that a dose leaves them as
refreshed as a short nap. Frequent fliers already get prescriptions for the stuff, and it is sure to be the next craze on 
college campuses among students who want to pull all-nighters or just be able to party hearty for days. Long-distance 
truck drivers are also obvious candidates for use and, perhaps, abuse.
Neurostimulation might improve cognition during confusing battles or offset sleep deprivation.
Workers who shift from day to night schedules and back again are also interested. They often complain of drowsiness 
during the work¿period and insomnia when they want to sleep. The Air Force Office of Scientific Research and
Cephalon, Inc., in Frazer, Pa., sponsored a study by Harvard University and the University of Pennsylvania in which 16 
healthy subjects were treated like shift workers: they were deprived of sleep for 28 hours, then obliged to sleep from 11 
A.M. to 7 P.M. for four days and to stay awake those nights. The subjects on modafinil did far better on cognitive tests 
than those on a sugar pill. Double-blinded, placebo-controlled studies have shown that some subjects can stay awake 
for more than 90 hours. 
A few news outlets have made unconfirmed claims that American soldiers were using modafinil on the way to Baghdad 
in 2003. That would not be surprising. Minimizing the need for sleep has been a holy grail for war planners since time 
immemorial. Guards at China's Great Wall chewed an herb containing ephedrine; Incan fighters munched on coca 
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leaves; 19th-century Bavarian officers gave their men cocaine; soldiers from several countries used amphetamines 
during World War II; and, of course, armies consume countless tons of caffeine and nicotine. French soldiers took 
modafinil in the first Gulf War, and the Guardian
newspaper reported in 2004 that the U.K.'s Ministry of Defense had purchased 24,000 tablets of the drug.
Preventing Mistakes
Despite the interest in modafinil, questions persist. Does it mask natural sleep needs but fall short in keeping people as 
functional as they think they are? This could be critical for pilots and soldiers, who should not overestimate their 
readiness. After prolonged use, the endocrine and immune systems may be compromised by lack of sleep, too.
Military scientists are examining the safety issues. One researcher at the air force's Brooks City-Base in San Antonio 
told Pentagram, an online newsletter, that "all indications say modafinil is a safer drug, but we don't know that for sure." 
But even if the compound proves safe in terms of sound judgment in combat, what about the effects down the road for 
people who have been on and off the drug for years? The long-term risks associated with sleep deprivation are not well 
understood either. Evidence indicates that during sleep, memory and learning are consolidated and that the brain 
refreshes its store of energy.
Studies have shown that people who sleep only four hours a day for an extended period have an increase in insulin 
resistance, a prediabetic symptom. But without a proven explanation for the purpose of sleep, it is hard to assess the 
downside of doing without, other than the obvious discomfort that nonsleepers experience--the attendant loss of 
concentration and the increased accident risks.
An intervention that minimizes the need for sleep yet maintains cognitive capacity would be a significant advantage for a
military force. Infantrymen commonly subsist on three or four hours of sleep nightly for weeks. Special Forces personnel
may be awake for several days during search and rescue operations. The Defense Advanced Projects Research 
Agency (DARPA) is spending $100 million in grants on "prevention of degradation of cognitive performance due to sleep
deprivation." DARPA's Defense Sciences Office has stated that "if you can prevent bad decisions from being made 
during sleep deprivation, you can dominate the battlefield." It is also interested in how to reverse losses that might occur 
during sleep deprivation and whether researchers can "expand the available memory space, so that people can retain 
cognitive function under tremendous stress and sleep deprivation."
The military effort includes investigation of another class of drugs, the ampakines, which show some promise in treating 
dementia and symptoms of schizophrenia by improving cognition when used with antipsychotic medication. Clinical trials
have not found therapeutic value, but results from a company-sponsored study at Wake Forest University using an 
ampakine drug in sleep-deprived rhesus monkeys were encouraging. The monkeys' performance was reduced 15 to 25 
percent when sleep-deprived, and reaction times doubled. But a single dose of Ampakine CX717 eliminated their 
performance deficit and sleep deprivation changes. An unpublished human trial sponsored by the company that makes 
CX717 reported that 16 men deprived of a night's sleep did better on memory and attention tests after taking the drug. 
The scientist who conducted the study said, "We didn't see any adverse events."
How Far Can We Go?
Military work is only the beginning of intense efforts to control sleep-wake cycles. There is a multibillion-dollar demand 
from civilians who wish to sleep only when they want to sleep. The neuroscientific key lies in a part of the hypothalamus 
called the suprachiasmatic nucleus (SCN), the brain's biological clock. About the size of a pinhead and nestled deep 
within the brain, the SCN, composed of 20,000 neurons, acts as the pacemaker for circadian rhythms in mammals. If the
SCN is cut or removed in animals, their sleep-wake cycle can be profoundly disturbed. And when people are deprived of
light, the SCN runs on a 25-hour clock; for some reason that is our innate length of a single day, which helps to explain 
insomnia and other sleep disorders in those who are blind. Though subject to some variation, the clock can be reset by 
exposure to light signals transmitted from the retina, which is why we can function on a regular 24-hour cycle. 
There are very few hard data showing that prolonged sleep deprivation has truly deleterious effects in humans, 
according to Harvard neurobiologist Jerome Groopman. Yet University of Pennsylvania researcher David Dinges has 
raised provocative questions about Boeing Company's plans for a jetliner that would fly around the earth and need to 
land only once in 20 hours: How should the crew sleep, if at all? What are the rules that apply to sustained work on 
flights like that? As Dinges says: "Now is the time to have an open and frank discussion on how far we will go as a 
culture. What are our priorities? How regularly do we want to manipulate our brain chemistry? What are the limits?"
Some insights may come from the animal world. Dolphins seem to keep parts of their brains awake to control their 
breathing and guide them to the surface for air while the rest of their brain is allowed to sleep. Otherwise they would 
drown. Positron-emission tomographic (PET) scans are beginning to reveal how their brain architecture accomplishes 
this feat. If the mechanism can somehow be simulated safely in human brains, it will be hard to keep the method out of 
the hands of civilians eager to get an edge in a competitive world.
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Electricity and Magnetism
Another approach to enhancing cognitive abilities may be electrical stimulation of select brain centers. Physicians at the 
Rehabilitation Institute of Chicago found that when they implanted electrodes in the motor cortex of stroke victims, 
patients regained about 30 percent of lost function as compared with 10 percent for other patients. Although the 
approach is not perfect, the gains for those whose arms had for years hung limply at their sides were wonderful. Some 
stroke patients with speech difficulties experienced improvement, too. Unfortunately, the doctors do not know exactly 
why the added electricity works.
Eliminating fear genes could satisfy parents who don't want to give birth to a "sissy."
An intriguing question is whether electrical stimulation might help uninjured people exceed their normal intellectual 
capacities. One technique being explored is direct-current (DC) polarization. At a 2004 Society for Neuroscience 
meeting, researchers from the National Institutes of Health reported that a tiny amount of electricity delivered to the 
brain through an electrode on the scalp produced measurable improvement in verbal skills. They asked volunteers to 
name as many words as possible that began with a certain letter. The subjects showed about a 20 percent improvement
when the current (two thousandths of an ampere, far less than that needed to run a digital watch) was on.
Because the current ran through the prefrontal cortex, the researchers speculated that the firing rate of neurons was 
increased, activating cells involved in word generation. The tiny charge seemed to have no deleterious effects, other 
than to leave certain individuals with an itchy scalp. Moreover, the fact that the technique does not involve surgery 
makes it more practical than implanted electrodes.
Another noninvasive technique is transcranial magnetic stimulation (TMS). A magnetic coil is placed above the head, 
and magnetic pulses pass through the cortex. Different kinds of pulses can alter the firing rate of different sets of 
neurons. Volunteers complain only about a sensation of tapping on the skull as scalp muscles contract and about a 
popping sound from the magnetic coil.
The therapeutic goal for DC polarization and TMS is to treat patients with stroke or dementia. TMS seems to target 
specific brain regions more effectively, but DC polarization appears to carry less risk of inducing seizures. Of course, the 
long-term effects of frequent exposure to electrical or magnetic stimulation are unknown. Nevertheless, DARPA has 
awarded research grants to explore whether neurostimulation can improve impaired cognitive performance in confusing 
battle circumstances or to offset sleep deprivation, perhaps through helmets that deliver the tiny impulses needed. 
Like so many potentially brain-enhancing technologies, neurostimulation can easily be oversold. Given how much we 
value cognition, however, even a modest improvement would be considered important by many people. Long-term 
problems for military personnel might be hard to identify and could seem worth the risk for even a marginal gain in 
mental agility in life-or-death situations. As neuroscientist Mark E. Huang of the Rehabilitation Institute of Chicago told
the press in 2004: "There are many possibilities that have to be answered ethically. If you want to learn a new language,
potentially the stimulator might help. Would I recommend you do it for that purpose? No. But down the road, who 
knows? Obviously the sky's the limit, and we're still in the infancy stage."
No Fear
Possibilities for mind enhancement indeed abound. A distinguished team of U.S. researchers reported in 2005 that a 
gene called stathmin, which is expressed in the amygdala (the seat of emotion), is associated with both innate and 
learned fear. The researchers bred mice without the gene and put them in aversive situations, such as giving them a 
mild shock at a certain point in their cage. Normal mice exhibited traditional fear behavior by freezing in place, but the 
altered mice froze less often. And when both types of mice were put in an open field environment--an innately 
threatening situation--the mice without stathmin
spent more time in the center of the field and explored more than the control mice.
Do individuals who have lesser stathmin
expression exhibit less fear? It is unlikely that there is a one-to-one correspondence, because humans are far more 
psychologically complex than mice, capable of modifying their genetically programmed behavior. Yet it is not difficult to 
imagine that a military official who overestimates the significance of genetic information will someday propose screening
Special Forces candidates, or even raw recruits, for the "fear gene." Indeed, a few years ago the Burlington Northern 
Santa Fe Railway Company had to pay $2.2 million to employees who had been secretly tested for a gene associated 
with carpal tunnel syndrome, even though the scientists who developed the testing technique said it could not work for 
that purpose. The company was trying to see if the workers' medical claims were attributable to their jobs or their genes.
If DNA testing for a fear gene is both scientifically and ethically dicey, what about setting out to create people who lack 
that characteristic? Would breeding humans without stathmin or other genes associated with fear reactions engender 
more courageous fighters? Would parents sign on for such meddling if they harbored ambitions for a child capable of a 
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glorious military career or just didn't want to give birth to a "sissy"? One problem, however, is that fear or its functional 
equivalent is one of those ancient properties exhibited by just about every animal. It surely has tremendous survival 
value. Removing it would be deeply counterevolutionary and would almost certainly generate numerous unintended and 
undesirable consequences for the individual, let alone thrust humans headlong into a fierce debate about whether 
enhancing ourselves has gone too far.
Proponents of such artificial enhancements argue that the changes may not be artificial at all. Is there even a valid 
distinction, they ask, between artificial and "natural" enhancements such as exercise and discipline? Aren't we just trying
to gain whatever advantages we can, as we have always tried to do, or are these techniques cheating nature? Can we 
manage the consequences, or are the risks for the individual and for humanity too great?
Is there even a distinction between artificial aids like drugs and "natural" ones like exercise?
These questions are part of an ongoing argument about whether we should use new discoveries in neuroscience and
other fields such as genetics to improve ourselves, our descendants and perhaps even the species. If it becomes 
acceptable to enhance civilians, then it would be hard to explain why national security agencies should be barred from 
giving war fighters an edge. And if it is not acceptable to enhance civilians, a special case might still be made for tuning 
up military personnel. 
National research on enhancement technologies will require the close involvement of advisory bodies with members 
both in government and outside it, with as much transparency as possible. Whereas some general principles should be 
articulated and become part of our regulatory framework, much of the hard work will have to be done on a case-by-case 
basis.
As Dinges notes, the debates are ones we haven't had. Libertarians would argue that government regulation would be 
overreaching, conservatives would worry about changing human nature, and liberals would worry about inequitable 
access to whatever advantages neuropharmacology might confer on those who are already relatively well off. All these 
views deserve to be aired, and the discussion needs to be moved onto our national policy agenda.
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